Free Trial

Patterson Companies (NASDAQ:PDCO) Now Covered by StockNews.com

Patterson Companies logo with Medical background
Remove Ads

Equities research analysts at StockNews.com started coverage on shares of Patterson Companies (NASDAQ:PDCO - Get Free Report) in a research note issued to investors on Thursday. The brokerage set a "hold" rating on the stock.

A number of other equities analysts have also issued reports on the stock. Piper Sandler decreased their price target on shares of Patterson Companies from $26.00 to $24.00 and set a "neutral" rating on the stock in a research note on Friday, December 6th. Leerink Partners reaffirmed a "market perform" rating and set a $31.35 price objective (up previously from $29.00) on shares of Patterson Companies in a report on Wednesday, December 11th. Robert W. Baird lifted their target price on Patterson Companies from $25.00 to $31.00 and gave the company a "neutral" rating in a research note on Thursday, December 12th. Leerink Partnrs lowered Patterson Companies from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Finally, Mizuho assumed coverage on Patterson Companies in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $23.00 price objective for the company. Eleven research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $26.57.

View Our Latest Analysis on Patterson Companies

Remove Ads

Patterson Companies Price Performance

PDCO stock traded down $0.04 during midday trading on Thursday, reaching $31.21. 837,579 shares of the company's stock traded hands, compared to its average volume of 1,056,420. The company has a quick ratio of 0.76, a current ratio of 1.37 and a debt-to-equity ratio of 0.34. The company has a market cap of $2.76 billion, a price-to-earnings ratio of 18.25, a PEG ratio of 2.71 and a beta of 0.99. The company has a 50-day simple moving average of $31.08 and a two-hundred day simple moving average of $26.51. Patterson Companies has a 1-year low of $19.45 and a 1-year high of $31.79.

Hedge Funds Weigh In On Patterson Companies

Hedge funds and other institutional investors have recently made changes to their positions in the company. Harbour Investments Inc. acquired a new stake in Patterson Companies during the 4th quarter worth $26,000. Huntington National Bank lifted its holdings in shares of Patterson Companies by 54.0% during the 4th quarter. Huntington National Bank now owns 1,115 shares of the company's stock valued at $34,000 after purchasing an additional 391 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Patterson Companies by 103.0% in the 4th quarter. GAMMA Investing LLC now owns 1,340 shares of the company's stock valued at $41,000 after purchasing an additional 680 shares during the period. Anchor Investment Management LLC increased its stake in Patterson Companies by 20.5% during the 3rd quarter. Anchor Investment Management LLC now owns 2,350 shares of the company's stock worth $51,000 after purchasing an additional 400 shares in the last quarter. Finally, Quadrant Capital Group LLC increased its stake in Patterson Companies by 501.6% during the 4th quarter. Quadrant Capital Group LLC now owns 1,883 shares of the company's stock worth $58,000 after purchasing an additional 1,570 shares in the last quarter. 85.43% of the stock is owned by institutional investors.

Patterson Companies Company Profile

(Get Free Report)

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.

Read More

Analyst Recommendations for Patterson Companies (NASDAQ:PDCO)

Should You Invest $1,000 in Patterson Companies Right Now?

Before you consider Patterson Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Patterson Companies wasn't on the list.

While Patterson Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads